472 related articles for article (PubMed ID: 27630014)
1. The synchronized trial on expectant mothers with depressive symptoms by omega-3 PUFAs (SYNCHRO): Study protocol for a randomized controlled trial.
Nishi D; Su KP; Usuda K; Chiang YJ; Guu TW; Hamazaki K; Nakaya N; Sone T; Sano Y; Tachibana Y; Ito H; Isaka K; Hashimoto K; Hamazaki T; Matsuoka YJ
BMC Psychiatry; 2016 Sep; 16(1):321. PubMed ID: 27630014
[TBL] [Abstract][Full Text] [Related]
2. Differences between Japan and Taiwan in the treatment of pregnant women with depressive symptoms by omega-3 fatty acids: An open-label pilot study.
Nishi D; Su KP; Usuda K; Chang JP; Chiang YJ; Guu TW; Hamazaki K; Nakaya N; Sone T; Hashimoto K; Hamazaki T; Matsuoka YJ
Nutr Neurosci; 2019 Jan; 22(1):63-71. PubMed ID: 28752805
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial.
Su KP; Huang SY; Chiu TH; Huang KC; Huang CL; Chang HC; Pariante CM
J Clin Psychiatry; 2008 Apr; 69(4):644-51. PubMed ID: 18370571
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 supplementation from pregnancy to postpartum to prevent depressive symptoms: a randomized placebo-controlled trial.
Vaz JDS; Farias DR; Adegboye ARA; Nardi AE; Kac G
BMC Pregnancy Childbirth; 2017 Jun; 17(1):180. PubMed ID: 28599630
[TBL] [Abstract][Full Text] [Related]
5. The Efficacy of Omega-3 Fatty Acids for Depressive Symptoms among Pregnant Women in Japan and Taiwan: A Randomized, Double-Blind, Placebo-Controlled Trial (SYNCHRO; NCT01948596).
Nishi D; Su KP; Usuda K; Pei-Chen Chang J; Chiang YJ; Chen HT; Chien YC; Guu TW; Okazaki E; Hamazaki K; Susukida R; Nakaya N; Sone T; Sano Y; Ito H; Isaka K; Tachibana Y; Tanigaki S; Suzuki T; Hashimoto K; Hamazaki T; Matsuoka YJ
Psychother Psychosom; 2019; 88(2):122-124. PubMed ID: 30540990
[No Abstract] [Full Text] [Related]
6. A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol.
Qurashi I; Chaudhry IB; Khoso AB; Farooque S; Lane S; Husain MO; Chu S; Sarginson J; Hamarani M; Naqvi HA; Razzaque B; Minhas FA; Yung AR; Deakin JFW; Husain N
Trials; 2017 Nov; 18(1):524. PubMed ID: 29121974
[TBL] [Abstract][Full Text] [Related]
7. Tachikawa project for prevention of posttraumatic stress disorder with polyunsaturated fatty acid (TPOP): study protocol for a randomized controlled trial.
Matsuoka Y; Nishi D; Yonemoto N; Hamazaki K; Matsumura K; Noguchi H; Hashimoto K; Hamazaki T
BMC Psychiatry; 2013 Jan; 13():8. PubMed ID: 23289548
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 polyunsaturated fatty acids and psychological intervention for workers with mild to moderate depression: A double-blind randomized controlled trial.
Tayama J; Ogawa S; Nakaya N; Sone T; Hamaguchi T; Takeoka A; Hamazaki K; Okamura H; Yajima J; Kobayashi M; Hayashida M; Shirabe S
J Affect Disord; 2019 Feb; 245():364-370. PubMed ID: 30423463
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 polyunsaturated fatty acids in cardiovascular diseases comorbid major depressive disorder - Results from a randomized controlled trial.
Chang JP; Chang SS; Yang HT; Chen HT; Chien YC; Yang B; Su H; Su KP
Brain Behav Immun; 2020 Mar; 85():14-20. PubMed ID: 30902738
[TBL] [Abstract][Full Text] [Related]
10. Supplementation of n-3 Polyunsaturated Fatty Acids for Major Depressive Disorder: A Randomized, Double-Blind, 12-Week, Placebo-Controlled Trial in Korea.
Park Y; Park YS; Kim SH; Oh DH; Park YC
Ann Nutr Metab; 2015; 66(2-3):141-148. PubMed ID: 25824637
[TBL] [Abstract][Full Text] [Related]
11. The mothers, Omega-3 and mental health study.
Mozurkewich E; Chilimigras J; Klemens C; Keeton K; Allbaugh L; Hamilton S; Berman D; Vazquez D; Marcus S; Djuric Z; Vahratian A
BMC Pregnancy Childbirth; 2011 Jun; 11():46. PubMed ID: 21696635
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D levels and perinatal depressive symptoms in women at risk: a secondary analysis of the mothers, omega-3, and mental health study.
Williams JA; Romero VC; Clinton CM; Vazquez DM; Marcus SM; Chilimigras JL; Hamilton SE; Allbaugh LJ; Vahratian AM; Schrader RM; Mozurkewich EL
BMC Pregnancy Childbirth; 2016 Aug; 16(1):203. PubMed ID: 27485050
[TBL] [Abstract][Full Text] [Related]
13. Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial.
Rice SM; Hickie IB; Yung AR; Mackinnon A; Berk M; Davey C; Hermens DF; Hetrick SE; Parker AG; Schäfer MR; McGorry PD; Amminger GP
Early Interv Psychiatry; 2016 Aug; 10(4):290-9. PubMed ID: 25130262
[TBL] [Abstract][Full Text] [Related]
14. Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial.
Jiang W; Whellan DJ; Adams KF; Babyak MA; Boyle SH; Wilson JL; Patel CB; Rogers JG; Harris WS; O'Connor CM
JACC Heart Fail; 2018 Oct; 6(10):833-843. PubMed ID: 30098961
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 polyunsaturated fatty acids (n-3 PUFAs), somatic and fatigue symptoms in cardiovascular diseases comorbid major depressive disorder (MDD): A randomized controlled trial.
Chang JP; Chang SS; Chen HT; Chien YC; Yang HT; Huang SY; Tseng PT; Chang CH; Galecki P; Su KP
Brain Behav Immun; 2023 Aug; 112():125-131. PubMed ID: 37301235
[TBL] [Abstract][Full Text] [Related]
16. Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial.
Okereke OI; Vyas CM; Mischoulon D; Chang G; Cook NR; Weinberg A; Bubes V; Copeland T; Friedenberg G; Lee IM; Buring JE; Reynolds CF; Manson JE
JAMA; 2021 Dec; 326(23):2385-2394. PubMed ID: 34932079
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 fatty acid supplementation for expectant mothers with depressive symptoms in Japan and Taiwan: An open-label trial.
Nishi D; Su KP; Usuda K; Chiang YJ; Guu TW; Hamazaki K; Nakaya N; Sone T; Sano Y; Ito H; Isaka K; Hashimoto K; Hamazaki T; Matsuoka YJ
Psychiatry Clin Neurosci; 2016 Jun; 70(6):253-4. PubMed ID: 27004997
[No Abstract] [Full Text] [Related]
18. Effects of omega-3 polyunsaturated fatty acids on psychophysiological symptoms of post-traumatic stress disorder in accident survivors: A randomized, double-blind, placebo-controlled trial.
Matsumura K; Noguchi H; Nishi D; Hamazaki K; Hamazaki T; Matsuoka YJ
J Affect Disord; 2017 Dec; 224():27-31. PubMed ID: 27287561
[TBL] [Abstract][Full Text] [Related]
19. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.
Andrieu S; Guyonnet S; Coley N; Cantet C; Bonnefoy M; Bordes S; Bories L; Cufi MN; Dantoine T; Dartigues JF; Desclaux F; Gabelle A; Gasnier Y; Pesce A; Sudres K; Touchon J; Robert P; Rouaud O; Legrand P; Payoux P; Caubere JP; Weiner M; Carrié I; Ousset PJ; Vellas B;
Lancet Neurol; 2017 May; 16(5):377-389. PubMed ID: 28359749
[TBL] [Abstract][Full Text] [Related]
20. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
